Inan El-Naggar A, Karakatsanis A, Valachis A. Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based study. AO [Internet]. 2025 Oct. 1 [cited 2026 May 30];64:1334-41. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/43990